PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40124C00115Medical and scientific writing editing for — Aneon Brillient, LLC

Aneon Brillient, LLC holds $21.2M across 24 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Aug 27, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Aneon Brillient, LLC

Recipient

Aug 27, 2027

PoP end

$1.6M

Obligated

$2.1M

Potential

561110

NAICS

R499

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number75F40124C00115

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentAneon Brillient, LLC

CAGE9CUL5

UEIMS8HMAY331Q5

NAICS561110

No full NAICS 561110 intel page yet. Browse NAICS intelligence

PSCR499

Place of performanceBELTSVILLE MD

Pricing typeLabor Hours

Extent competedNot Competed

Related solicitation75F40124R00139

PoP startAug 21, 2024

PoP end (current)Aug 27, 2027

PoP end (w/ options)Aug 27, 2028

Obligated$1.6M

Current value$1.6M

Potential value$2.1M

Medical and Scientific Writing & Editing for the Center for Drug Evaluation and Research (CDER) is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Aneon Brillient, LLC. Estimated value $2.1M ($1.6M obligated). Current period of performance ends Aug 27, 2027 (potential Aug 27, 2028). Last award drew 1 bidder. Place of performance: BELTSVILLE MD. Related solicitation 75F40124R00139.

Medical and scientific writing & editing for the center for drug evaluation and research (cder). Latest action is a modification.

Recompete timing

Public

● Expiring in 314 days

Current PoP ends Aug 27, 2027 (314 days remaining). Agencies typically plan 12–18 months ahead — at 10.3 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 75F40124C00115? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Aneon Brillient, LLC — $21.2M obligated across 24 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($21.2M) · all agencies

Department of Health and Human Services (HHS)$21.2M · 100%General Services Administration (GSA)$2K · 0%

Open full company profile →

Related awards

Same incumbent

75F40124C00034

TRANSCRIPTION SERVICES TO SUPPORT CDER ADVISORY MEETINGS. TO PROVIDE SUPPORT SERVICES AND …

$643K

Feb 27, 2027

75F40124C00133

FDA/OFFICE OF REGULATORY AFFAIRS OFFICE OF TRAINING, EDUCATION, AND DEVELOPMENT (OTED) SHI…

$409K

Mar 29, 2027

75F40124P00138

DIRECT 8(A) AWARD OF A 3-YEAR, FFP-TYPE PURCHASE ORDER TO EXPAND DEVELOPMENT AND MAINTENAN…

$363K

May 6, 2027

75F40126C00027

DIRECT 8(A) AWARD, STAND-ALONE, LABOR-HOUR (LH) TYPE CONTRACT FOR FOOD AND DRUG ADMINISTRA…

$1.9M

Aug 11, 2027

75F40124C00085

DIRECT 8(A) AWARD OF A 3-YEAR, LABOR-HOUR (LH) TYPE CONTRACT FOR COMMUNICATION, ADMINISTRA…

$2.4M

Aug 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40124C00115?

75F40124C00115 (Medical and scientific writing editing for) is a Fda Office Of Acq Grant Svcs award with a potential value of $2.1M, currently held by Aneon Brillient, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40124C00115?

Fda Office Of Acq Grant Svcs awarded 75F40124C00115 to Aneon Brillient, LLC (potential $2.1M).

Who is the incumbent on 75F40124C00115?

Aneon Brillient, LLC is the incumbent with $21.2M across 24 related awards in SCOUT’s public footprint. The current period of performance ends Aug 27, 2027.

When does Aneon Brillient, LLC’s 75F40124C00115 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 27, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40124C00115? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 23, 2026 · refreshed monthlyLatest procurement action Jun 24, 2026